Reappraisal of FDA approved drugs against Alzheimer’s disease based on differential gene expression and protein interaction network analysis: an in silico approach

References

• Adlard, P. A., Bica, L., White, A. R., Nurjono, M., Filiz, G., Crouch, P. J., … Bush, A. I. (2011). Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer’s disease. PLoS One, 6(3), e17669. doi:10.1371/journal.pone.0017669
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. (2018). 2018 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 14(3), 367–429. 10.1016/j.jalz.2018.02.001
   Web of Science ®Google Scholar
• Ambure, P., Bhat, J., Puzyn, T., & Roy, K. (2019). Identifying natural compounds as multi-target-directed ligands against Alzheimer’s disease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 37(5), 1282–1306. doi:10.1080/07391102.2018.1456975
   PubMed Web of Science ®Google Scholar
• Andreoli, V., De Marco, E. V., Trecroci, F., Cittadella, R., Di Palma, G., & Gambardella, A. (2013). Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease. Journal of Neural Transmission, 121(5), 533–542. 10.1007/s00702-013-1125-7
   PubMed Web of Science ®Google Scholar
• Association, A., & Alzheimer’s Association. (2017). FDA-approved treatments for Alzheimer’s. Retrieved from https://www.alz.org/dementia/downloads/topicsheet_treatments.pdf%0Afile:///D:/002 current projects/003 NO APPROVAL/9999 review projects/ALZ REVIEW/AD new trial review [email protected]/ALZHEIMER REVIEW.Data/PDF/3492138826/topicsheet_treatments.pdf
   Google Scholar
• Barrett, T., & Edgar, R. (2006). Gene expression omnibus: Microarray data storage, submission, retrieval, and analysis. Methods in Enzymology, 411, 352–369. 10.1016/S0076-6879(06)11019-8
   PubMed Web of Science ®Google Scholar
• Baumann, U., Huber, R., Bode, W., Grosse, D., Lesjak, M., & Laurell, C. B. (1991). Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. Journal of Molecular Biology, 218(3), 595–606. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2016749 doi:10.1016/0022-2836(91)90704-A
   PubMed Web of Science ®Google Scholar
• Bijnsdorp, I. V., Peters, G. J., Temmink, O. H., Fukushima, M., & Kruyt, F. A. (2010). Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells. International Journal of Cancer, 126(10), 2457-2468. doi:10.1002/ijc.24943
   PubMed Web of Science ®Google Scholar
• Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., … Galon, J. (2009). ClueGO: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics, 25(8), 1091–1093. doi:10.1093/bioinformatics/btp101
   PubMed Web of Science ®Google Scholar
• Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010). Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews Neurology, 6(3), 131–144. doi:10.1038/nrneurol.2010.4
   PubMed Web of Science ®Google Scholar
• Brown, G. R., Hem, V., Katz, K. S., Ovetsky, M., Wallin, C., Ermolaeva, O., … Murphy, T. D. (2015). Gene: A gene-centered information resource at NCBI. Nucleic Acids Research, 43(D1), D36–D42. doi:10.1093/nar/gku1055
   PubMed Web of Science ®Google Scholar
• Cao, L.-L., Pei, X.-F., Qiao, X., Yu, J., Ye, H., Xi, C.-L., … Gong, Z.-L. (2018). SERPINA3 silencing inhibits the migration, invasion, and liver metastasis of colon cancer cells. Digestive Diseases and Sciences, 63(9), 2309–2319. 10.1007/s10620-018-5137-x
   PubMed Web of Science ®Google Scholar
• Chuang, Y.-F., Breitner, J. C. S., Chiu, Y.-L., Khachaturian, A., Hayden, K., Corcoran, C., … Zandi, P. P. (2014). Use of diuretics is associated with reduced risk of Alzheimer’s disease: The Cache County Study. Neurobiology of Aging, 35(11), 2429–2435. doi:10.1016/j.neurobiolaging.2014.05.002
   PubMed Web of Science ®Google Scholar
• Clark, N. R., Hu, K. S., Feldmann, A. S., Kou, Y., Chen, E. Y., Duan, Q., & Ma’ayan, A. (2014). The characteristic direction: A geometrical approach to identify differentially expressed genes. BMC Bioinformatics, 15(1), 79. doi:10.1186/1471-2105-15-79
   PubMedGoogle Scholar
• Clinicaltrials.gov. (2018). Retrieved from https://clinicaltrials.gov/ct2/show/NCT02002819?term=levetiracetam&cond=Alzheimer+Disease&rank=2
   Google Scholar
• Cutinho, P. F., Roy, J., Anand, A., Cheluvaraj, R., Murahari, M., & Chimatapu, H. S. V. (2019). Design of metronidazole derivatives and flavonoids as potential non-nucleoside reverse transcriptase inhibitors using combined ligand- and structure-based approaches. Journal of Biomolecular Structure and Dynamics, 1–23. doi:10.1080/07391102.2019.1614094
   PubMed Web of Science ®Google Scholar
• Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., … Zlokovic, B. (2003). RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nature Medicine, 9(7), 907–913. doi:10.1038/nm890
   PubMed Web of Science ®Google Scholar
• Fitz, N. F., Tapias, V., Cronican, A. A., Castranio, E. L., Saleem, M., Carter, A. Y., … Koldamova, R. (2015). Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice. Brain, 138(12), 3699–3715. doi:10.1093/brain/awv293
   PubMedGoogle Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. doi:10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Gundersen, G. W., Jones, M. R., Rouillard, A. D., Kou, Y., Monteiro, C. D., Feldmann, A. S., … Ma’ayan, A. (2015). GEO2Enrichr: Browser extension and server app to extract gene sets from GEO and analyze them for biological functions: Fig. 1. Bioinformatics, 31(18), 3060–3062. doi:10.1093/bioinformatics/btv297
   PubMed Web of Science ®Google Scholar
• Halgren, T. (2007). New method for fast and accurate binding-site identification and analysis. Chemical Biology & Drug Design, 69(2), 146–148. doi:10.1111/j.1747-0285.2007.00483.x
   PubMed Web of Science ®Google Scholar
• Hema Sree, G., Saraswathy, G., Manikanta, M., & Mamatha, K. (2019). An update on drug repurposing: Re-written saga of the drug’s fate. Biomedicine & Pharmacotherapy, 110, 700–716. 10.1016/j.biopha.2018.11.127
   PubMed Web of Science ®Google Scholar
• Hokama, M., Oka, S., Leon, J., Ninomiya, T., Honda, H., Sasaki, K., … Nakabeppu, Y. (2014). Altered expression of diabetes-related genes in Alzheimer’s disease brains: The Hisayama study. Cerebral Cortex, 24(9), 2476–2488. doi:10.1093/cercor/bht101
   PubMed Web of Science ®Google Scholar
• Hung, S. Y., & Fu, W. M. (2017). Drug candidates in clinical trials for Alzheimer’s disease. Journal of Biomedical Science, 24(1), 1–12. doi:10.1186/s12929-017-0355-7
   PubMedGoogle Scholar
• Hunter, S., & Brayne, C. (2012). Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems. Alzheimer's Research & Therapy, 4(2), 10. doi:10.1186/alzrt108
   PubMed Web of Science ®Google Scholar
• Imai, S., Cai, T., Yoshida, C., Tomita, T., & Futai, E. (2018). Specific mutations in presenilin 1 cause conformational changes in γ-secretase to modulate amyloid beta trimming. The Journal of Biochemistry, 165, 37–46. doi:10.1093/jb/mvy081
   Web of Science ®Google Scholar
• Iqbal, S., Anantha Krishnan, D., & Gunasekaran, K. (2018). Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics, 36(15), 4029–4044. doi:10.1080/07391102.2017.1406824
   PubMed Web of Science ®Google Scholar
• Jha, N. K., Jha, S. K., Kumar, D., Kejriwal, N., Sharma, R., Ambasta, R. K., & Kumar, P. (2015). Impact of insulin degrading enzyme and neprilysin in Alzheimer’s disease biology: Characterization of putative cognates for therapeutic applications. Journal of Alzheimer's Disease, 48(4), 891–917. doi:10.3233/JAD-150379
   PubMed Web of Science ®Google Scholar
• Ji, Z.-S., Miranda, R. D., Newhouse, Y. M., Weisgraber, K. H., Huang, Y., & Mahley, R. W. (2002). Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells. Journal of Biological Chemistry, 277(24), 21821–21828. doi:10.1074/jbc.M112109200
   PubMed Web of Science ®Google Scholar
• Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., … McConlogue, L. (1997). Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proceedings of the National Academy of Sciences of United States of America, 94(4), 1550–1555. doi:10.1073/pnas.94.4.1550
   PubMed Web of Science ®Google Scholar
• Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017). KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Research, 45(D1), D353–D361. doi:10.1093/nar/gkw1092
   PubMed Web of Science ®Google Scholar
• Keenan, A. B., Jenkins, S. L., Jagodnik, K. M., Koplev, S., He, E., Torre, D., … Pillai, A. (2018). The library of integrated network-based cellular signatures NIH Program: System-level cataloging of human cells response to perturbations. Cell Systems, 6(1), 13–24. doi:10.1016/j.cels.2017.11.001
   PubMed Web of Science ®Google Scholar
• Kimura, A., Hata, S., & Suzuki, T. (2016). Alternative selection of β-site APP-cleaving enzyme 1 (BACE1) cleavage sites in amyloid β-protein precursor (APP) harboring protective and pathogenic mutations within the Aβ sequence. Journal of Biological Chemistry, 291(46), 24041–24053. doi:10.1074/jbc.M116.744722
   PubMed Web of Science ®Google Scholar
• Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., … Wishart, D. S. (2014). DrugBank 4.0: Shedding new light on drug metabolism. Nucleic Acids Research, 42(D1), D1091–D1097. doi:10.1093/nar/gkt1068
   PubMed Web of Science ®Google Scholar
• Li, H., Gao, Z., Kang, L., Zhang, H., Yang, K., Yu, K., … Jiang, H. (2006). TarFisDock: A web server for identifying drug targets with docking approach. Nucleic Acids Research, 34(Web Server), W219–W224. doi:10.1093/nar/gkl114
   PubMedGoogle Scholar
• Licastro, F., Chiappelli, M., Caldarera, C. M., Porcellini, E., Carbone, I., Caruso, C., … Corder, E. H. (2011). Sharing pathogenetic mechanisms between acute myocardial infarction and Alzheimer’s disease as shown by partially overlapping of gene variant profiles. Journal of Alzheimer's Disease, 23(3), 421–431. doi:10.3233/JAD-2010-090871
   PubMed Web of Science ®Google Scholar
• Luo, D., Chen, W., Tian, Y., Li, J., Xu, X., Chen, C., & Li, F. (2017). Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients. OncoTargets and Therapy, 10, 2173–2181. doi:10.2147/OTT.S133022
   PubMed Web of Science ®Google Scholar
• Lyne, P. D., Lamb, M. L., & Saeh, J. C. (2006). Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. Journal of Medicinal Chemistry, 49(16), 4805–4808. doi:10.1021/jm060522a
   PubMed Web of Science ®Google Scholar
• Mackin, R. S., Insel, P., Zhang, J., Mohlenhoff, B., Galasko, D., Weiner, M., & Mattsson, N. (2014). Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer’s disease. Journal of Alzheimer's Disease, 43(3), 1007–1016. doi:10.3233/JAD-141287
   Web of Science ®Google Scholar
• Majores, M., Kölsch, H., Bagli, M., Ptok, U., Kockler, M., Becker, K., … Heun, R. (2002). The insulin gene VNTR polymorphism in Alzheimer’s disease: Results of a pilot study. Journal of Neural Transmission, 109(7–8), 1029–1034. doi:10.1007/s007020200086
   PubMed Web of Science ®Google Scholar
• Mariga, A., Zavadil, J., Ginsberg, S. D., & Chao, M. V. (2015). Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function. Developmental Neurobiology, 75(2), 173–192. doi:10.1002/dneu.22216
   PubMed Web of Science ®Google Scholar
• Mustafa, S., Walker, A., Bennett, G., & Wigmore, P. M. (2008). 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. European Journal of Neuroscience, 28(2), 323–330. doi:10.1111/j.1460-9568.2008.06325.x
   PubMed Web of Science ®Google Scholar
• Nho, K., Kim, S., Horgusluoglu, E., Risacher, S. L., Shen, L., Kim, D., … Saykin, A. J, …; Alzheimer’s Disease Neuroimaging Initiative (ADNI). (2017). Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease. BMC Medical Genomics, 10(S1), 29. doi:10.1186/s12920-017-0267-0
   PubMedGoogle Scholar
• Robinson, R. C., Radziejewski, C., Stuart, D. I., & Jones, E. Y. (1995). Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. Biochemistry, 34(13), 4139–4146. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7703225 doi:10.1021/bi00013a001
   PubMed Web of Science ®Google Scholar
• Rose, P. W., Bi, C., Bluhm, W. F., Christie, C. H., Dimitropoulos, D., Dutta, S., … Bourne, P. E. (2012). The RCSB Protein Data Bank: New resources for research and education. Nucleic Acids Research, 41(D1), D475–D482. doi:10.1093/nar/gks1200
   PubMed Web of Science ®Google Scholar
• Sassi, C., Guerreiro, R., Gibbs, R., Ding, J., Lupton, M. K., Troakes, C., … Hardy, J. (2014). Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer’s disease. Neurobiology of Aging, 35(12), 2881.e1–2881.e6. doi:10.1016/j.neurobiolaging.2014.06.002
   Web of Science ®Google Scholar
• Scacchi, R., Gambina, G., Moretto, G., & Corbo, R. M. (2009). Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer’s disease and relationships with response to treatment with donepezil and rivastigmine. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150(4), 502–507. doi:10.1002/ajmg.b.30846
   Google Scholar
• Schrötter, A., Pfeiffer, K., El Magraoui, F., Platta, H. W., Erdmann, R., Meyer, H. E., … Müller, T. (2012). The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer’s disease. Molecular & Cellular Proteomics, 11(11), 1274–1288. doi:10.1074/mcp.M112.019364
   PubMed Web of Science ®Google Scholar
• Shi, J.-Q., Wang, B.-R., Tian, Y.-Y., Xu, J., Gao, L., Zhao, S.-L., … Zhang, Y.-D. (2013). Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice. CNS Neuroscience & Therapeutics, 19(11), 871–881. doi:10.1111/cns.12144
   PubMed Web of Science ®Google Scholar
• Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017). Role of LRP1 in the pathogenesis of Alzheimer’s disease: Evidence from clinical and preclinical studies. Journal of Lipid Research, 58(7), 1267–1281. doi:10.1194/jlr.R075796
   PubMed Web of Science ®Google Scholar
• Shukla, R., & Singh, T. R. (2019). Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics, 1–15. doi:10.1080/07391102.2019.1571947
   Google Scholar
• Vanni, S., Moda, F., Zattoni, M., Bistaffa, E., De Cecco, E., Rossi, M., … Legname, G. (2017). Differential overexpression of SERPINA3 in human prion diseases. Scientific Reports, 7(1), 15637. doi:10.1038/s41598-017-15778-8
   PubMedGoogle Scholar
• von Mering, C., Huynen, M., Jaeggi, D., Schmidt, S., Bork, P., & Snel, B. (2003). STRING: A database of predicted functional associations between proteins. Nucleic Acids Research, 31(1), 258–261. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12519996 doi:10.1093/nar/gkg034
   PubMed Web of Science ®Google Scholar
• Wojsiat, J., Laskowska-Kaszub, K., Alquézar, C., Białopiotrowicz, E., Esteras, N., Zdioruk, M., … Wojda, U. (2017). Familial Alzheimer’s disease lymphocytes respond differently than sporadic cells to oxidative stress: Upregulated p53-p21 signaling linked with presenilin 1 mutants. Molecular Neurobiology, 54(7), 5683–5698. doi:10.1007/s12035-016-0105-y
   PubMed Web of Science ®Google Scholar
• Yang, G.-D., Yang, X.-M., Lu, H., Ren, Y., Ma, M.-Z., Zhu, L.-Y., … Zhang, Z.-G. (2014). SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis. International Journal of Clinical and Experimental Pathology, 7(4), 1348–1358. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24817931
   PubMed Web of Science ®Google Scholar
• Yasar, S., Xia, J., Yao, W., Furberg, C. D., Xue, Q.-L., Mercado, C. I., … Carlson, M. C. (2013). Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo evaluation of memory study. Neurology, 81(10), 896–903. doi:10.1212/WNL.0b013e3182a35228
   PubMed Web of Science ®Google Scholar
• Zhou, J., Cheng, Y., Tang, L., Martinka, M., & Kalia, S. (2017). Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells. Oncotarget, 8(12), 18712–18725. doi:10.18632/oncotarget.9409
   PubMedGoogle Scholar
• Zhou, J., Li, X.-M., Jiang, T., Liu, Y., Chi, S., Yu, J.-T., & Tan, L. (2013). Lack of association between COMT Val158Met polymorphism and late-onset Alzheimer’s disease in Han Chinese. Neuroscience Letters, 554, 162–166. doi:10.1016/j.neulet.2013.09.006
   PubMed Web of Science ®Google Scholar
• Zuccato, C., & Cattaneo, E. (2009). Brain-derived neurotrophic factor in neurodegenerative diseases. Nature Reviews Neurology, 5(6), 311–322. doi:10.1038/nrneurol.2009.54
   PubMed Web of Science ®Google Scholar